Corsicana & Co’s GSK GSK Stock Holding History

Corsicana & Co’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.24K	Hold	100	–	–	﹤0.01%	252
2026 Q1	$3.87K	Hold	100	–	–	﹤0.01%	224
2025 Q4	$4.9K	Hold	100	–	–	﹤0.01%	212
2025 Q3	$4.32K	Buy	+100	New	+$3.91K	﹤0.01%	221
2022 Q3	–	Sell	-1,460	Closed	-$79K	–	211
2022 Q2	$79K	Hold	1,460	–	–	0.06%	111
2022 Q1	$79K	Hold	1,460	–	–	0.05%	118
2021 Q4	$80K	Hold	1,460	–	–	0.05%	115
2021 Q3	$70K	Hold	1,460	–	–	0.04%	120
2021 Q2	$73K	Buy	+1,460	New	+$70.2K	0.05%	117

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Corsicana & Co's GSK Position: Q2 2026 in Review

Corsicana & Co held its GSK (GSK) position steady in Q2 2026 at 100 shares worth $5.24K. The position accounts for ﹤0.01% of the portfolio, ranked #252.

Corsicana & Co first reported a position in GSK in Q2 2021 and has held it in 9 quarters since. The position peaked at $80K in Q4 2021. 1,043 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Corsicana & Co held 100 shares of GSK worth $5.24K as of Q2 2026.
Corsicana & Co left its GSK share count unchanged in Q2 2026.
GSK made up ﹤0.01% of Corsicana & Co's portfolio in Q2 2026, its #252 holding.
Corsicana & Co first reported a position in GSK in Q2 2021 and has held it in 9 quarters since.
Corsicana & Co's GSK position peaked at $80K in Q4 2021.
1,043 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Corsicana & Co's 13F filing for Q2 2026, filed 24 Jul 2026.